Vistagen Faces Class Action Over Alleged Misstatements on Fasedienol Trial Data
Class action lawsuit filed against $VTGN alleging securities fraud over fasedienol drug trial statements and concealed adverse clinical data.
VTGNsecurities fraudclass action lawsuit